LeapFrog Investments makes full exit from Goodlife Pharmacy to CFAO Healthcare
It says its exit marks a key moment for African healthcare, which has historically been underfunded and underpenetrated by private capital
LeapFrog Investments has announced its successful exit from Goodlife Pharmacy, East Africa’s largest retail pharmacy programme, after its acquisition by CFAO Healthcare, a leading distributor of pharmaceutical and healthcare products in Africa.
The full exit follows the sale of a minority stake in the company to CFAO Healthcare in 2022, which marked the beginning of a strategic partnership between them with CFAO now buying the remainder of its shareholding to take up full ownership.
LeapFrog’s investment in Goodlife in 2017 helped accelerate a modern pharmacy retail category that did not exist before in East Africa by emphasising traceable supply chains and scaling a trusted consumer-focused brand that now serves more than two million consumers annually.
“Goodlife has evolved into East Africa’s leading health services provider offering pharmaceuticals, beauty and wellness products as well as a suite for diagnostic and primary care consultation services with the support of licensed partners. The chain enables access to affordable and quality health care products and services to fast-growing communities across the region. Today, the business operates an integrated omni-channel model with around 150 locations across Kenya and Uganda,” it said.
Goodlife added that its exit marks a key moment for African healthcare, which has historically been underfunded and underpenetrated by private capital.
“Goodlife’s growth demonstrates that private investments in African healthcare is not only viable but can also deliver strong financial returns alongside life-changing impact,” the statement said.
It quoted LeapFrog Partner and Global Head of Healthcare Dr Biju Mohandas as saying the exit is a powerful demonstration of what is possible in African healthcare with the right capital and the right partner.
“Together with a world-class management team, we built Goodlife into a household name – trusted by millions for vital medicines and health services. With its more than 70-year history and rich legacy of operating in Africa, CFAO Healthcare, the healthcare subsidiary of the Toyota Group, is the ideal partner to carry this mission forward.”
LeapFrog’s hands-on operational support focused on transitioning Goodlife to an asset-light, profitable business model, with a keen focus on improving unit economics via targeted initiatives on product assortment, supply chain optimisation, store rollout and capital deployment. Through its Talent Accelerator programme, LeapFrog supported the recruitment of a skilled executive team and the implementation of best-in-class systems. Work with LeapFrog’s CX program propelled the launch of Goodlife’s digital and deliveries business and its customer loyalty program, myGoodlifeClub. which has more than 500,000 members. These initiatives enabled Goodlife to scale sustainably, build strong customer engagement, demonstrating resilience and clear market differentiation even through the COVID-19 pandemic and broader macroeconomic headwinds.
CFAO Healthcare CEO Jean-Marc Leccia said: “Goodlife has built a trusted brand and an extensive network of pharmacies across East Africa. Thanks to LeapFrog’s operational expertise and vision, the platform now stands as a benchmark for delivering affordable, high-quality care to emerging consumers. Goodlife has built a highly recognised brand and an extensive network of pharmacies that serve as genuine wellness hubs. Together, we will further enhance accessibility, service quality, and innovation within the pharmaceutical sector.”
Goodlife Pharmacy CEO Justin Melvin said: “Goodlife Pharmacy has always been dedicated to enhancing health and wellness, and with the backing of LeapFrog Investments, we’ve achieved tremendous progress toward our mission. Partnering with CFAO Healthcare offers a unique opportunity to expand that mission, delivering greater impact and value for our customers and communities.”
CFAO Healthcare’s acquisition reflects Goodlife’s strong market position, operational sophistication, and long-term growth prospects. As part of Toyota Tsusho Corporation, CFAO brings extensive pan-African reach and resources that will help accelerate Goodlife’s next phase of growth.
The transaction has received all regulatory approvals. Lead advisors to LeapFrog Investments included Nedbank and I&M Burbridge (Financial) and Bowman’s (Legal and Competition).
